Renal Cancer - Results from #240

REVIEW UroToday

Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma, "Beyond the Abstract," by Michael Aitchison, MD, FRCS March 18, 2014

Renal cell carcinoma with venous tumor thrombus extension: A retrospective study of factors affecting survival, "Beyond the Abstract," by Kazuto Ito, MD, PhD and Mikio Kobayashi, MD, PhD March 18, 2014

Metastatic renal cell carcinoma: How to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor, "Beyond the Abstract," by Roberto Sabbatini, MD, et al March 5, 2014

Differentiation, with multiphase CT, of clear cell renal cell carcinoma and papillary renal cell carcinoma, two distinct histological types, "Beyond the Abstract," by David Laszlo Tarnoki, MD, et al February 13, 2014

Development of a clinical prediction model for assessment of malignancy risk in Bosniak III renal lesions, "Beyond the Abstract," by Ajit H. Goenka, MD and Erick M. Remer, MD February 12, 2014

Urine screening by surface-enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry followed by biomarker identification, "Beyond the Abstract," by Gilda Alves, PhD and Antonio Augusto Ornellas, MD, PhD January 14, 2014

Management of locally advanced renal cell carcinoma with invasion of the duodenum, "Beyond the Abstract," by Andrew T. Schlussel, DO and Linda L. Wong, MD January 11, 2014

A review of current management considerations for the incidentally detected small renal mass, "Beyond the Abstract," by Philippe E. Spiess, MD, MS, FRCS(C), FACS November 12, 2013

Association with disease-free and cancer-specific survival in lymphovascular invasion in clear cell renal cell carcinoma, "Beyond the Abstract," by Michael Belsante, MD November 7, 2013

Cumulative number of altered biomarkers in mTOR gene pathway is an independent predictor of outcome in patients with clear cell renal cell carcinoma, "Beyond the Abstract," by Oussama Darwish, MD and Vitaly Margulis, MD November 2, 2013

Pneumocystis pneumonia associated with everolimus therapy for renal cell carcinoma: A case report, "Beyond the Abstract," by Yoshinobu Saito, MD, PhD October 16, 2013

Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy, "Beyond the Abstract," by Robert Uzzo, MD, FACS, et al October 4, 2013

Coexistent metastatic melanoma of the kidney with unknown primary and renal cell carcinoma, "Beyond the Abstract," by Melinda B. Chu, MD and John M. Richart, MD October 3, 2013

Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomas, "Beyond the Abstract," by François Cornelis, MD, et al. September 24, 2013

Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: Implications for multimodal therapy, "Beyond the Abstract," by Umberto Capitanio, MD September 20, 2013

A case of tumor seeding at the time of ablative therapy for clinically localized renal cell carcinoma: A rare complication, "Beyond the Abstract," by Arash Akhavein, MD September 18, 2013

Fusion in urology, "Beyond the Abstract," by Hayet Amalou, MD September 17, 2013

Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma? "Beyond the Abstract," by Pierre-Emmanuel Falcoz, et al September 12, 2013

Why study carboxypeptidase M in the human kidney? Because it is there, "Beyond the Abstract," by Anne-Marie Lambeir September 4, 2013

Increased visceral obesity is associated with higher Fuhrman grade in patients with cT1a renal cell carcinoma, "Beyond the Abstract," by Hongkai Wang August 22, 2013

Page 13 of 16